2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice …

FLJ Visseren, F Mach, YM Smulders… - European heart …, 2021 - academic.oup.com
Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …

[HTML][HTML] Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension

B Zhou, P Perel, GA Mensah, M Ezzati - Nature Reviews Cardiology, 2021 - nature.com
High blood pressure is one of the most important risk factors for ischaemic heart disease,
stroke, other cardiovascular diseases, chronic kidney disease and dementia. Mean blood …

[HTML][HTML] Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

CJL Murray, KS Ikuta, F Sharara, L Swetschinski… - The lancet, 2022 - thelancet.com
Background Antimicrobial resistance (AMR) poses a major threat to human health around
the world. Previous publications have estimated the effect of AMR on incidence, deaths …

[PDF][PDF] The global burden of metabolic disease: Data from 2000 to 2019

NWS Chew, CH Ng, DJH Tan, G Kong, C Lin, YH Chin… - Cell Metabolism, 2023 - cell.com
Global estimates of prevalence, deaths, and disability-adjusted life years (DALYs) from the
Global Burden of Diseases, Injuries, and Risk Factors Study 2019 were examined for …

[HTML][HTML] Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

GBD Collaborators, VL Feigin, BA Stark… - The Lancet …, 2021 - escholarship.org
BackgroundRegularly updated data on stroke and its pathological types, including data on
their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are …

[HTML][HTML] Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

VL Feigin, BA Stark, CO Johnson, GA Roth… - The Lancet …, 2021 - thelancet.com
Background Regularly updated data on stroke and its pathological types, including data on
their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are …

Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070

I Soerjomataram, F Bray - Nature reviews Clinical oncology, 2021 - nature.com
Cancer is currently the first or second most common contributor to premature mortality in
most countries of the world. The global number of patients with cancer is expected to rise …

[HTML][HTML] Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990 …

MB Reitsma, PJ Kendrick, E Ababneh, C Abbafati… - The Lancet, 2021 - thelancet.com
Background Ending the global tobacco epidemic is a defining challenge in global health.
Timely and comprehensive estimates of the prevalence of smoking tobacco use and …

[HTML][HTML] Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990 …

GBD 2019 Tobacco Collaborators - Lancet (London, England), 2021 - ncbi.nlm.nih.gov
Background Ending the global tobacco epidemic is a defining challenge in global health.
Timely and comprehensive estimates of the prevalence of smoking tobacco use and …

Global epidemiology of dyslipidaemias

A Pirillo, M Casula, E Olmastroni, GD Norata… - Nature Reviews …, 2021 - nature.com
Dyslipidaemias are alterations to the plasma lipid profile that are often associated with
clinical conditions. Dyslipidaemias, particularly elevated plasma LDL-cholesterol levels, are …